Oncology Central

Regulatory T cells in cancer; can they be controlled?


Natural regulatory T (Treg) cells, described as CD4+CD25+Foxp3+ cells have long been established as a subset of T lymphocytes critical for maintaining tolerance to self-constituents [1]. Their suppressive activities however extend beyond self tolerance as they have been demonstrated to regulate various facets of immune responses against allergens, microbial and infectious agents, as well as tissue-derived alloantigens [1]. Mounting evidence also shows their increased presence in cancer settings, often coinciding with attenuated antitumor T-cell responses [2].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.